The licensed cannabis producer Tilray has become one of the few cannabis business with a female majority on their board of directors. Today, they welcomed Rebekah Dopp, Maryscott "Scotty" Greenwood and Christine St.Clare to their Board, writes Calvin Hughes.

As the movement to legalize recreational cannabis use gains momentum, investors are looking to get in on the action in any way they can. And that's a huge win for Canada because it's basically the only game in town, writes Brandon Hicks.

Cannabis production is ramping up across Canada in preparation for recreational sales becoming legal. The House of Commons on June 18 voted 205-82 to accept an amended version of Canada’s Cannabis Act, which would legalize recreational cannabis use countrywide.

The bill now passes back to the Senate, where senators will vote on the new version of the bill – one that includes many of the amendments that the Senate voted on June 7 to approve, but not all of those amendments.

Members of the province’s veterinary community say it may not be the high life for some dogs when marijuana becomes legalized in Canada.

According to a news release from the Manitoba Veterinary Medical Association, there are concerns because pot can potentially be toxic to companion animals, especially dogs, who are far more sensitive to the effects of THC — which is found in hemp and marijuana plants — than people, and that can make recreational marijuana use dangerous to a canine companion.

Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that further to its January 18 th, 2018 letter of intent ("LOI"), that the Company has signed a subscription agreement (the "Agreement") to acquire 10% of the issued share capital of Israeli licensed producer of medical cannabis, Cannbit Ltd ("Cannbit") for NIS 2,500,000 or approximately CAD $908,000, which includes a combination of both cash and shares.

Markers Insurance has announced it will offer what it claims is the country’s first guaranteed issue insurance product for individuals providing coverage for medical cannabis prescriptions. It expects to initially launch an individual product by August 15, followed by a group product for companies wishing to provide such benefits to their employees.

Markers Insurance is known as the agent of record for The Alternative Health Association of Canada, a national non-profit formed to advocate for improved patient outcomes through health and wellness alternatives. The brokerage is a division of Toronto-based Evergreen Pacific Insurance Corporation (EPIC), which was founded in late 2017.

The upcoming legalization of cannabis for adult use will close Canada’s near century-long prohibition on recreational cannabis and provide a new legal framework while building a safe foundation for a world-class cannabis economy.

Our country has developed a commendable system for a legal cannabis market. Canada will soon be a globally recognized leader of cannabis legalization, regulation and production and the first G7 country to legalize it for medical and recreational use.

The government’s approval of the Cannabis Act will set a promising industry into motion, generating opportunities for consumers, licensed producers (LPs), suppliers, employees and investors.

Investors looking to leverage the marijuana industry can soon do so, with three new exchange-traded funds (ETFs) set to launch later this summer.

Horizons ETF Management Canada Inc. filed preliminary documents with regulators last week to launch three new ETFs on the Toronto Stock Exchange that will focus on leveraging the cannabis sector.

Leveraged ETFs – also known as “double ETFs” – typically aim to deliver two or three times the return on their stated index, and carry a higher risk rating than typical ETFs.

In covering the cannabis mania which has taken the Canadian stock market by storm in recent years, the high levels of consolidation within the cannabis sector, categorized by increasingly unrealistic valuation multiples, is, to me, reminiscent of the bio-pharmaceutical sector just a few years ago. In early 2015, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could do no wrong. The company was buying companies at 30%, 40%, 50%, or higher premiums to valuations on a regular basis. Investors ignored the implications of the multiples Valeant chose to pay for its targets, choosing instead to focus on the future potential of the synergies of said…

The federal point-man on pot, Bill Blair, says that if the legislation to legalize marijuana passes by the end of the week, the government will eye a September date to implement the new regime.

"Upon Royal Assent a decision will be made by the government as to a date of implementation," Blair said in an interview on CTV’s Question Period. "We're probably looking at a date of implementation somewhere towards the beginning of September, perhaps mid-September."

The Cannabis Act is currently in a temporary state of legislative limbo, after the House of Commons rose early Friday following a 12-hour voting marathon.